EPIC Nitinol Stent System in the Treatment of Atherosclerotic Lesions in Iliac Arteries
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The ORION study is being conducted to determine whether the Epic™ Nitinol Stent for primary
stenting of iliac atherosclerotic lesions shows acceptable performance at 9 months.